Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Methods
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Clinical tools — Methods
Youth — Methods
Wednesday, 23 October
10:50
Innovative methods for exploring new drug-related trends
10:50
to
12:20
Insights zone 4 (I4)
João Matias
12:20
Measuring drug use to monitor trends in different populations - ISSDP poster session 1
12:20
to
13:20
Guided poster tours room
Nicola Singleton
15:00
Needs-based planning for substance use treatment systems: The new generation of principles, methods and models
15:00
to
16:30
Insights zone 4 (I4)
Thomas Babor
16:50
My virtual reality in counselling: digital reading & writing in text-based online-addiction-counselling
16:50
to
18:20
Futures zone 3 (F3)
Ilias Paraskevopoulos
18:30
Workforce development and training
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Innovative approaches for assessing or impacting demand for substances
18:30
to
19:30
Central square 1 (C1)
Anne Line Bretteville-Jensen
Thursday, 24 October
10:50
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
12:20
Making better use of existing data through standardisation, methods and analysis - ISSDP poster session 2
12:20
to
13:20
Guided poster tours room
Rosalie Pacula
13:20
Infusing policy with evidence
13:20
to
14:50
Central square 3 (C3)
Lara Tavoschi
Using new technology and innovative methods to measure substance use and related harm
13:20
to
14:50
Networking zone 1 (N1)
Peter Reuter
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
15:00
Methodological challenges and comparative analyses in five European countries
Insight into the dynamics of substance use (research) in nightlife settings
15:00
to
16:30
Networking zone 1 (N1)
João Matias
Emerging issues in the management of conflicts of interest
15:00
to
16:30
Insights zone 1 (I1)
Niamh Fitzgerald
Treatment interventions
15:00
to
16:30
Networking zone 3 (N3)
Kari Grasaasen
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
16:50
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
Striving towards the future elimination of Hep C among people who use drugs
16:50
to
18:20
Futures zone 1 (F1)
Eberhard Schatz
Perrine Roux
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
11:00
Oral presentation
Lessons learned from 25 years of drug checking in the Netherlands
11:00
to
11:15
Insights zone 4 (I4)
Laura Smit-Rigter
11:15
Oral presentation
Harm reduction agencies and monitoring the responses to drug-related harm
11:15
to
11:30
Insights zone 4 (I4)
Tuukka Tammi
11:30
Oral presentation
Monitoring drug use through wastewater analysis in Spain
11:30
to
11:45
Insights zone 4 (I4)
José Benito Quintana
11:45
Oral presentation
ESCAPE (European Syringe Collection & Analysis Project Enterprise): a multi-city study of monitoring consumption trends of people who inject drugs
11:45
to
12:00
Insights zone 4 (I4)
Thomas Néfau
12:20
Poster
Illegal drug trends in Taiwan, 2009-2018
12:20
to
13:20
Guided poster tours room
Kai-Hsiang Kang
Poster
Gender convergence in alcohol consumption: outcomes from general population survey on drugs, Portugal 2001-2016/17
12:20
to
13:20
Guided poster tours room
Clara Vital
Poster
Monitoring recreational drug use in Switzerland
12:20
to
13:20
Guided poster tours room
Dominique Schori
Poster
Prevalence and patterns of drug use indicator (‘GPS’)
12:20
to
13:20
Guided poster tours room
Federica Mathis
Poster
European web survey on drugs: patterns of use
12:20
to
13:20
Guided poster tours room
João Matias
15:10
Oral presentation
Measuring unmet demand for alcohol and other treatment: the application of an Australian population-based planning model
15:10
to
15:25
Insights zone 4 (I4)
Alison Ritter
15:25
Oral presentation
The treatment demand indicator in Europe: A common monitoring tool across 30 countries and its value for treatment systems planning
15:25
to
15:40
Insights zone 4 (I4)
Linda Montanari
15:40
Oral presentation
Development of a needs-based planning model to estimate required capacity of a substance use treatment system: A Canadian model
15:40
to
15:55
Insights zone 4 (I4)
Brian Rush
15:55
Oral presentation
Users of alcohol and other drugs residing in the Metropolitan Region of São Paulo: Basis for the planning of a treatment system
15:55
to
16:10
Insights zone 4 (I4)
Daniela Mota
16:10
Oral presentation
The evolution of methods to estimate specialist alcohol treatment capacity and access in the United Kingdom
16:10
to
16:25
Insights zone 4 (I4)
Colin Drummond
18:30
Short communication
The peer in outreach teams: a specialist among specialists?
18:30
to
18:40
Networking zone 3 (N3)
Maria João Oliveira
Oral presentation
USODROGAS.PT: Portugal's drug use: a web based survey
18:30
to
18:45
Central square 1 (C1)
André Tadeu
18:40
Short communication
The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace
18:40
to
18:50
Networking zone 3 (N3)
Camilla Lynne Bakkeng
18:45
Oral presentation
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
18:45
to
19:00
Central square 1 (C1)
Henning Pettersen
18:50
Short communication
Experiences of marketised welfare organisations among addiction treatment staff in Sweden
18:50
to
19:00
Networking zone 3 (N3)
Jessica Storbjörk
19:00
Short communication
Preparing effective addiction workforce: a challenge from the Czech perspective
19:00
to
19:10
Networking zone 3 (N3)
Amalie Pavlovská
Oral presentation
Validation of the Routine Opioid Outcome Monitoring (ROOM) screening tool in patients prescribed opioids for chronic pain
19:00
to
19:15
Central square 1 (C1)
Suzanne Nielsen
19:10
Short communication
Workforce development: the great paradox for the addictions sector
19:10
to
19:20
Networking zone 3 (N3)
Ann Roche
19:15
Oral presentation
Adoption of publication procedures to improve research integrity by alcohol and other drug journals
19:15
to
19:30
Central square 1 (C1)
Dennis Gorman
19:20
Short communication
Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services
19:20
to
19:30
Networking zone 3 (N3)
Robert Calder
Thursday, 24 October
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
12:00
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
12:20
Poster
Epidemiology of illicit drug use and policy evaluation: the heroin epidemics example
12:20
to
13:20
Guided poster tours room
Carla Rossi
Poster
Scalable family therapy training materials for adolescents with substance use disorder (UNFT)
12:20
to
13:20
Guided poster tours room
Anja Busse
Poster
Community Reinforcement and Family Training (CRAFT) - a cluster randomised controlled trial comparing individual, group and self-help interventions.
12:20
to
13:20
Guided poster tours room
Randi Bilberg
Poster
Can environmental prevention effectively complement efforts in responding to the psychoactive substance abuse among forensic patients?
12:20
to
13:20
Guided poster tours room
Poster
Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders
12:20
to
13:20
Guided poster tours room
Annette Dale-Perera
Anja Busse
Poster
Preliminary methodological analysis on the lexicometric assessment of laws and drugs policies and evaluation of social outcomes
12:20
to
13:20
Guided poster tours room
Carla Rossi
Poster
Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders
12:20
to
13:20
Guided poster tours room
Wataru Kashino
13:20
Poster
Trends on the Dutch drug market identified by DIMS in 2018
13:20
to
14:50
Guided poster tours room
Laura Smit-Rigter
Poster
Gendered sources of drug supply for recreational drug users in the European Web Survey on Drugs
13:20
to
14:50
Guided poster tours room
Michael Vuolo
Poster
Trends in primary substance mentioned by patients entering treatment for illicit substance use in Belgium between 2012 and 2018
13:20
to
14:50
Guided poster tours room
Antoine Jérôme
Poster
Criminal reactions and reduction of crime and drug use in drug-using offenders
13:20
to
14:50
Guided poster tours room
Olga Souza Cruz
Poster
Fatal traffic accidents in connection to driving under the influence of psychoactive substances
13:20
to
14:50
Guided poster tours room
Ada Hocevar Grom
Poster
HIV infection in drug users in harm reduction structures
13:20
to
14:50
Guided poster tours room
Isabel Ponte
Poster
Drug-related deaths and mortality in Europe
13:20
to
14:50
Guided poster tours room
Federica Mathis
Poster
Demand for drug treatment in Europe: the Treatment Demand indicator (TDI)
13:20
to
14:50
Guided poster tours room
Linda Montanari
Poster
Non-medical prescription drug use among Estonian adults
13:20
to
14:50
Guided poster tours room
Sigrid Vorobjov
Poster
Monitoring drug-related infectious diseases in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
Poster
Estimating the number of people who inject drugs (PWID) in Europe
13:20
to
14:50
Guided poster tours room
Thomas Seyler
13:30
Oral presentation
'A more accurate understanding of drug use': a critical analysis of wastewater analysis technology for drug policy
13:30
to
13:45
Networking zone 1 (N1)
Kari Lancaster
Oral presentation
Translating research into policy: is 'advocacy' a dirty word?
13:30
to
13:45
Central square 3 (C3)
Alison Ritter
13:45
Oral presentation
Beyond the substances: a multi-criteria analysis of spread of drugs in Europe
13:45
to
14:00
Networking zone 1 (N1)
Giuliano Resce
Oral presentation
Addiction practitioners and drug policy reform
13:45
to
14:00
Central square 3 (C3)
Kasia Malinowska-Sempruch
14:00
Oral presentation
A smartphone app to assess alcohol consumption behaviours: development, validity, compliance and reactivity
14:00
to
14:15
Networking zone 1 (N1)
Rob Hester
Oral presentation
Individual vulnerability as core risk factor for gambling disorder: implications for public health and gambling policies
14:00
to
14:15
Central square 3 (C3)
Gerhard Bühringer
14:15
Oral presentation
New and fully automated workflow for alcohol consumption and drugs of abuse monitoring from one single blood droplet
14:15
to
14:30
Networking zone 1 (N1)
Marc Luginbühl
Oral presentation
Drug use in rural and suburban environments: challenges in a progressive drug policy setting
14:15
to
14:30
Central square 3 (C3)
Ludmila Carapinha
14:30
Oral presentation
Application of a preliminary 'qualitative' leximetric approach via an example: anti-drug laws, policies and social outcomes in Italy since 2000.
14:30
to
14:45
Central square 3 (C3)
Carla Rossi
15:00
Oral presentation
Why are COIs still a current issue? Recent issues & Examples
15:00
to
15:05
Insights zone 1 (I1)
Niamh Fitzgerald
Oral presentation
Why are COIs still a current issue?
15:00
to
16:30
Insights zone 1 (I1)
Niamh Fitzgerald
15:05
Oral presentation
Conflicts of interest and the emerging cannabis industry
15:05
to
15:15
Insights zone 1 (I1)
James Nicholls
15:10
Short communication
Psychedelic-assisted psychotherapy for the treatment of addictions: The future of addiction treatment?
15:10
to
15:20
Networking zone 3 (N3)
Anton Gomez-Escolar
Oral presentation
‘EMSS Nightlife survey’: design and snapshot of findings in 5 European countries
15:10
to
15:25
Networking zone 1 (N1)
Meryem Grabski
Oral presentation
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
15:10
to
15:25
Insights zone 4 (I4)
Daan van der Gouwe
15:15
Oral presentation
Conflict of interest declarations and dilemmas for addiction journals
15:15
to
15:25
Insights zone 1 (I1)
Thomas Babor
15:20
Short communication
Drug addiction in the immigrant population of users undergoing the low-threshold methadone maintenance programme in Lisbon
15:20
to
15:30
Networking zone 3 (N3)
Hugo Faria
15:25
Oral presentation
Methodological challenges: comparing different samples and sampling strategies
15:25
to
15:40
Networking zone 1 (N1)
Jon Waldron
Panel discussion
15:25
to
15:40
Insights zone 1 (I1)
Niamh Fitzgerald
James Nicholls
Thomas Babor
15:30
Short communication
Employment influence in recovering people who use drugs during opiate substitution treatment
15:30
to
15:40
Networking zone 3 (N3)
Ângela Leite
15:40
Short communication
Working with complex families with parental substance abuse: an overview of the parents under pressure program
15:40
to
15:50
Networking zone 3 (N3)
Sharon Dawe
Oral presentation
Ecological momentary assessment of substance use (consequences) among ecstasy users
15:40
to
15:55
Networking zone 1 (N1)
Ruben van Beek
Oral presentation
A descriptive analysis of the illicit supply of new psychoactive substances within and from China
15:40
to
15:55
Insights zone 4 (I4)
Minqi Zhao
Oral presentation
Three primary principles in making decisions on relationships with funders and organisations with vested interests
15:40
to
15:55
Insights zone 1 (I1)
Niamh Fitzgerald
15:55
Oral presentation
Contextual analysis and comparison of nightlife cultures in five European countries
15:55
to
16:10
Networking zone 1 (N1)
Tina Van Havere
Oral presentation
MDMA dosage in XTC tablets: size matters
15:55
to
16:10
Insights zone 4 (I4)
Ruben Vrolijk
Scenario-based roundtable interactive or group discussion
15:55
to
16:30
Insights zone 1 (I1)
Niamh Fitzgerald
Thomas Babor
James Nicholls
16:10
Oral presentation
Insight into the reliability of self-report of substance use in nightlife populations: a breath sampling study
16:10
to
16:25
Networking zone 1 (N1)
Kristin Feltmann
Oral presentation
Understanding drug markets: results of the MARSTUP study
16:10
to
16:25
Insights zone 4 (I4)
Frank Zobel
16:50
Oral presentation
A community-based peer-driven program to reach people who inject drugs, monitor risk behaviours and 'test and treat' for infectious diseases in Athens, Greece: ARISTOTLE HCV-HIV
16:50
to
17:05
Futures zone 1 (F1)
Vana Sypsa
17:00
Oral presentation
Interpreting wastewater data alongside other population-level indicators of stimulant use
17:00
to
17:15
Central square 2 (C2)
Hayley Jones
17:05
Oral presentation
Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study
17:05
to
17:20
Futures zone 1 (F1)
Jason Grebely
17:15
Oral presentation
What are the indirect causes of death among people who use drugs in Ireland? Findings from a comprehensive special register on drug related deaths
17:15
to
17:30
Central square 2 (C2)
Suzi Lyons
17:20
Oral presentation
Low HCV-RNA prevalence and low anti HCV incidence in a large national sample of PWID in opioid substitution treatment in Germany: a prospective cohort study
17:20
to
17:35
Futures zone 1 (F1)
Bernd Schulte
17:30
Oral presentation
Temporary and constant remission: a record-linkage study of a national cohort of people with psychoactive drug use disorders
17:30
to
17:45
Central square 2 (C2)
Morten Hesse
17:35
Oral presentation
Monitoring the elimination of hepatitis C and B among people who inject drugs in Europe
17:35
to
17:50
Futures zone 1 (F1)
Thomas Seyler
17:45
Oral presentation
Effective policies to support autonomous attempts to quit opioid use - a cross-sectional study across 14 countries
17:45
to
18:00
Central square 2 (C2)
Larissa Maier
17:50
Oral presentation
'Towards eliminating viral hepatitis': A critical examination of the performativity of hepatitis C elimination goals and targets
17:50
to
18:05
Futures zone 1 (F1)
Kari Lancaster
18:05
Oral presentation
Evidencing viral elimination futures: modelling, targets and the end of Hep C
18:05
to
18:20
Futures zone 1 (F1)
Tim Rhodes